Biliary Stents Market

Key Players: Companies such as Boston Scientific (US), Medtronic (US), Cook Medical (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Hobbs Medical (US), ConMed Corporation (US), Olympus Corporation (JP), Stryker Corporation (US) are some of the major participants in the Global Biliary Stents Market.

Biliary Stent Market

Biliary Stent Market Research Report By Material (Plastic, Metal, Biodegradable), By Design (Single Stent, Double Stent, Triple Stent), By Diameter ( 7 Fr, 7 - 10 Fr, > 10 Fr), By Length ( 10 cm, 10 - 20 cm, > 20 cm), By Application (Benign Biliary Strictures, Malignant Biliary Strictures, Choledocholithiasis) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/HS/7513-HCR
100 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: May 15, 2026
Request Free Sample

Biliary Stent Market Summary

The Global Biliary Stents Market size was valued at USD 643.3 Million in 2024, and the market is projected to grow from USD 677.8 Million in 2025 to USD 1,142.72 Million by 2035, registering a CAGR of 5.36% during the forecast period 2025–2035. North America led the market in 2024 with over 50.00% share, generating around USD 321.65 Million in revenue. North America led the market with over 50.00% share, generating around USD 321.65 million in revenue.
 
The Biliary Stents Market is growing due to increasing prevalence of biliary diseases, rising incidence of gallstones and bile duct cancers, and growing demand for minimally invasive procedures. Key trends include advancements in metal and biodegradable stents, increasing use in palliative cancer care, and expanding adoption of endoscopic treatments.
 
Gallbladder and biliary-related diseases affect over 100 million people worldwide, highlighting the growing clinical need for interventional treatments.

Key Market Trends & Highlights

The Biliary Stents Market is poised for growth driven by technological advancements and increasing healthcare needs.

  • North America remains the largest market for biliary stents, driven by advanced healthcare infrastructure and high patient awareness.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare expenditure and a growing population.
  • Biliary obstruction is the largest segment, while cholangiocarcinoma is noted as the fastest-growing segment within the market.
  • Technological advancements and the rising incidence of biliary disorders are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 643.3 (USD Million)
2035 Market Size 1142.72 (USD Million)
CAGR (2025 - 2035) 5.36%

Major Players

Companies such as Boston Scientific (US), Medtronic (US), Cook Medical (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Hobbs Medical (US), ConMed Corporation (US), Olympus Corporation (JP), Stryker Corporation (US) are some of the major participants in the Global Biliary Stents Market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Biliary Stent Market Trends

The biliary stents market is currently experiencing a notable evolution, driven by advancements in medical technology and an increasing prevalence of biliary disorders. As healthcare systems worldwide prioritize minimally invasive procedures, the demand for effective stenting solutions has surged across the global biliary stent market and related segments such as the pancreatic and biliary stents market. This market appears to be characterized by a diverse range of products, including plastic and metal stents, each designed to address specific clinical needs. Within this landscape, the biliary plastic stents market and metal biliary stent market are gaining significant traction due to their widespread clinical applications. Furthermore, the growing awareness of the benefits associated with biliary stenting, such as improved patient outcomes and reduced recovery times, seems to be influencing the biliary stents market dynamics significantly.

In addition, the biliary stents market is likely to witness a shift towards innovative materials and designs that enhance the functionality and longevity of stents. Manufacturers are increasingly focusing on developing biocompatible materials that minimize complications and improve patient comfort. Moreover, the integration of advanced technologies, such as drug-eluting stents, indicates a potential trend towards personalized treatment options in the pancreatic and biliary stent market as well. As the market continues to evolve, stakeholders must remain vigilant to emerging trends and adapt their strategies accordingly to maintain a competitive edge in the global pancreatic biliary stent market and related therapeutic areas.

Technological Advancements

The biliary stents market is witnessing a surge in technological innovations, particularly in the development of drug-eluting stents. These advanced devices are designed to release medication over time, potentially reducing the risk of restenosis and improving patient outcomes. As healthcare providers increasingly adopt these technologies, the market is likely to expand, driven by the demand for more effective treatment options within the metal biliary stent market and the broader pancreatic and biliary stents market.

  • According to the World Health Organization, minimally invasive and device-based interventions are increasingly prioritized in healthcare systems globally to improve patient outcomes and reduce complications. Additionally, the Centers for Disease Control and Prevention highlights the growing adoption of advanced medical technologies in gastrointestinal and interventional procedures, while the European Centre for Disease Prevention and Control supports innovation in medical devices to enhance treatment efficiency and patient safety across healthcare settings.

Rising Incidence of Biliary Disorders

An increase in the prevalence of biliary disorders is driving demand for biliary stents. As more individuals are diagnosed with conditions such as cholangiocarcinoma and biliary strictures, the need for effective treatment options is becoming more critical.

  • According to the Global Burden of Disease Study by Institute for Health Metrics and Evaluation, digestive diseases account for hundreds of millions of cases globally, with a significant burden linked to hepatobiliary conditions. Furthermore, the World Health Organization reports that cancers such as liver and bile duct cancers contribute to over 800,000 deaths annually worldwide, reinforcing the growing need for interventional treatments like biliary stenting.

Focus on Minimally Invasive Procedures

There is a growing emphasis on minimally invasive techniques within the Biliary Stents Market. Healthcare providers are increasingly adopting these approaches to reduce recovery times and improve overall patient experiences.

  • The World Health Organization emphasizes the increasing global shift toward minimally invasive procedures to reduce hospital stays and improve recovery outcomes. In addition, the Pan American Health Organization promotes the adoption of less invasive surgical and interventional techniques across healthcare systems, while programs supported by UNICEF highlight improved patient outcomes and faster recovery times associated with modern medical interventions.

Biliary Stent Market Drivers

Market Growth Projections

The Global Biliary Stent Market Industry is projected to experience substantial growth in the coming years. The market value is expected to rise from 0.64 USD Billion in 2024 to 1.14 USD Billion by 2035, reflecting a compound annual growth rate of 5.37% from 2025 to 2035.
 
This growth trajectory suggests a robust demand for biliary stents driven by factors such as increasing incidence of biliary disorders, technological advancements, and rising healthcare expenditures. As the market evolves, stakeholders are likely to focus on innovation and improving patient outcomes, further solidifying the industry's position in the global healthcare landscape.

Growing Geriatric Population

The aging population worldwide is a significant driver for the Global Biliary Stent Market Industry. Older adults are more susceptible to biliary disorders, necessitating medical interventions such as stenting. According to demographic studies, the global population aged 65 and older is projected to reach 1.5 billion by 2050.
 
This demographic shift is likely to increase the demand for biliary stents, as older patients often present with complex health issues requiring specialized care. Consequently, healthcare systems are adapting to meet this growing need, further fueling market growth as they invest in advanced biliary stenting solutions.

Increasing Healthcare Expenditure

Rising healthcare expenditure across various regions is positively impacting the Global Biliary Stent Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to advanced medical technologies, including biliary stents. For instance, countries in Asia-Pacific are witnessing significant increases in healthcare budgets, which facilitate the procurement of innovative stenting solutions.
 
This trend is expected to enhance the availability of biliary stents in hospitals and clinics, thereby driving market growth. As healthcare spending continues to rise, the market is likely to benefit from increased adoption rates and improved patient outcomes.

Rising Incidence of Biliary Disorders

The Global Biliary Stent Market Industry is experiencing growth due to the increasing prevalence of biliary disorders, such as cholangiocarcinoma and gallstones. These conditions necessitate the use of biliary stents for effective management and treatment.
 
For instance, the World Health Organization indicates that the incidence of cholangiocarcinoma is rising globally, particularly in regions with high rates of liver disease. As more patients require intervention, the demand for biliary stents is expected to rise, contributing to the market's expansion. This trend is anticipated to drive the market value from 0.64 USD Billion in 2024 to an estimated 1.14 USD Billion by 2035.

Regulatory Approvals and Market Expansion

The Global Biliary Stent Market Industry is also influenced by the regulatory landscape, which plays a crucial role in market expansion. Recent approvals for new biliary stent products by health authorities have opened up opportunities for manufacturers to introduce innovative solutions.
 
For example, the approval of new drug-eluting stents has provided clinicians with more options for managing biliary obstructions. These regulatory advancements not only enhance competition among manufacturers but also improve patient care by offering safer and more effective treatment options. As more products gain approval, the market is likely to see increased growth and diversification.

Technological Advancements in Stent Design

Innovations in biliary stent technology are propelling the Global Biliary Stent Market Industry forward. Advanced materials and designs, such as biodegradable stents and drug-eluting stents, enhance patient outcomes and reduce complications. For example, the introduction of self-expanding metal stents has improved the efficacy of biliary drainage procedures.
 
These advancements not only improve the quality of care but also increase the adoption rates among healthcare providers. As the market evolves, these technological improvements are likely to attract investment and drive growth, potentially leading to a compound annual growth rate of 5.37% from 2025 to 2035.

Market Segment Insights

By Application: Biliary Stricture (Largest) vs. Cholangiocarcinoma (Fastest-Growing)

In the Biliary Stents Market, the application segment exhibits diverse distribution among its key values: biliary obstruction, biliary stricture, cholangiocarcinoma, and pancreatic cancer. Biliary stricture currently holds the largest share of 36%, driven by an increasing prevalence of chronic liver disease and other obstructive pathologies that necessitate stenting interventions. Comparatively, cholangiocarcinoma, while smaller in share, is rapidly ascending due to rising awareness and advancements in targeted therapies that enhance its treatment profile.

Biliary Stricture (Dominant) vs. Cholangiocarcinoma (Emerging)

Biliary stricture is recognized as the dominant application in the biliary stents market, largely due to its association with prevalent conditions such as biliary obstruction and pancreatitis. Its established treatment protocols and the growing patient demographic needing intervention for stricture management position it as a cornerstone of biliary stenting. On the other hand, cholangiocarcinoma represents an emerging segment fueled by increasing incidence rates and developments in early detection technologies. This malignancy is progressively attributed to enhanced survival rates associated with stenting, reflecting a shift in treatment paradigms as more patients are diagnosed at earlier stages, thereby driving the demand for biliary stents designed specifically for this purpose.

By Type: Metal Stents (Largest) vs. Covered Stents (Fastest-Growing)

In the Biliary Stents Market, Metal Stents currently hold the largest market share of 58% due to their superior durability and effectiveness in longer-term applications. This segment's appeal lies in its ability to provide reliable patency rates compared to other stent types. Conversely, Covered Stents are gaining traction among healthcare providers and patients, leading to a rapid increase in their market presence, primarily attributed to advancements in design and enhanced efficacy in preventing bile duct strictures.

Metal Stents (Dominant) vs. Covered Stents (Emerging)

Metal Stents are recognized for their robust structure and ability to remain patent over extended periods, making them the dominant choice for chronic biliary obstructions. They offer advantages such as reduced re-intervention rates and successful management of bile flow. On the other hand, Covered Stents are emerging as a strong competitor due to their unique design which helps minimize tissue ingrowth and provides a barrier against bile leakage. Their growing popularity is linked to consistent improvements in biocompatibility and patient outcomes, appealing to medical professionals looking for effective treatment options.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Biliary Stents Market, hospitals hold the largest market share of 62% among end users, leveraging their comprehensive facilities and expertise in complex procedures. Ambulatory Surgical Centers (ASCs) follow as a significant segment, appealing mainly due to their cost-effective solutions for less complex stenting procedures. Specialty clinics also contribute to the market, attracting patients with their specialized care, although they have a smaller overall share compared to hospitals and ASCs. The growth trends within this segment are driven by increasing rates of biliary diseases, an aging population, and advancements in minimally invasive stenting techniques. Hospitals benefit from larger patient volumes and robust infrastructure, while ASCs are rapidly expanding due to shifts towards outpatient care. Specialty clinics are gaining traction as they offer targeted services and personalized patient experiences, meeting the specific needs of biliary stent patients.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals dominate the Biliary Stents Market, primarily due to their extensive resources, multidisciplinary teams, and capability to perform complex procedures. They are often preferred for intricate cases where comprehensive care is needed, thereby driving significant patient traffic. In comparison, Ambulatory Surgical Centers are emerging as a vital segment, providing a more efficient and cost-effective environment for outpatient biliary stent procedures. The trend towards outpatient surgeries is fueling ASC growth, attracting patients seeking convenience and lower costs. Both segments play crucial roles in patient outcomes, with hospitals focusing on high-acuity cases, while ASCs cater to patients looking for quicker and safer recovery options.

By Material: Polymer (Largest) vs. Metal (Fastest-Growing)

In the Biliary Stents Market, Polymer stents hold the largest share of 55% due to their favorable properties such as flexibility, biocompatibility, and durability. These attributes make them a preferred choice among healthcare professionals for treating biliary obstructions. Metal stents, on the other hand, have been gaining traction as the fastest-growing segment because of their strength and ability to maintain patency over time, especially in challenging anatomical configurations. The growth of the Metal segment is driven by advancements in stent design and materials, making them suitable for a wider range of patients. Newer technologies, such as drug-eluting metal stents, are attracting attention for their potential to minimize complications and improve patient outcomes. This trend is further enhanced by the increasing prevalence of biliary disorders, which continues to stimulate market demand.

Polymer (Dominant) vs. Metal (Emerging)

In the Biliary Stents Market, Polymer stents are recognized as the dominant force, celebrated for their lightweight nature, flexibility, and ease of deployment, providing a lower risk of complication. These stents have a long history of successful use, making them a trusted option for practitioners. On the contrary, Metal stents are emerging in the market owing to superior strength and resistance to collapse, offering extended patency and reduced occlusion rates. With innovative designs incorporating features such as drug-release capabilities, Metal stents are making significant inroads as hospital protocols evolve, thus appealing to a broader healthcare audience. The competition between these materials is shaping the future direction of the biliary stent landscape.

By Design: Expandable Stents (Largest) vs. Curved Stents (Fastest-Growing)

In the Biliary Stents Market, the design segment showcases a competitive landscape where expandable stents dominate with significant market share of 61%, owing to their versatility and enhanced functionality in biliary duct applications. Straight stents, while established, are witnessing reduced demand as healthcare providers increasingly turn to designs that offer improved patient outcomes and adaptability during procedures. On the other hand, curved stents have emerged as a favorite in recent years, driven by technological advancements and better patient comfort, gradually increasing their share in the market. The growth trends indicate a shift towards stents that combine ease of insertion with optimal therapeutic efficacy. The increasing prevalence of biliary diseases, along with advancements in stent technology, supports the expanding use of both expandable and curved stents. Furthermore, rising awareness regarding the benefits of tailored stent designs fuels the demand, as they provide more effective solutions for individual patient needs in biliary interventions.

Design: Expandable Stents (Dominant) vs. Curved Stents (Emerging)

Expandable stents have established themselves as the dominant choice in the biliary stents market due to their ability to expand and adapt to the size of the bile duct, thereby minimizing complications and enhancing patient outcomes. Their advanced design features allow for greater flexibility during placement, making them suitable for a wider array of clinical scenarios. In contrast, curved stents represent an emerging trend, gaining traction for their ability to navigate the complex anatomy of the biliary system. As procedural techniques advance and focus shifts towards personalized medicine, both expandable and curved stents play critical roles in improving the effectiveness of biliary interventions, appealing to healthcare providers aiming for higher procedural success rates.

Get more detailed insights about Biliary Stent Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America leads in the Biliary Stents Market Size, accounting for over 50.00% of the global revenue in 2024. The growth is driven by increasing incidences of biliary diseases, advancements in stent technology, and supportive regulatory frameworks. The demand for minimally invasive procedures is also on the rise, further propelling market expansion. Regulatory bodies are actively promoting innovations that enhance patient outcomes, contributing to a robust market environment. 

The competitive landscape in North America is characterized by the presence of major players such as Boston Scientific, Medtronic, and Cook Medical. These companies are investing heavily in R&D to develop advanced biliary stents that cater to diverse patient needs. The U.S. remains the largest market, followed by Canada, with a growing focus on improving healthcare access and affordability. This competitive edge is expected to sustain the region's dominance in the global market.

The Global Fund to Fight AIDS, Tuberculosis and Malaria reports that over 50 million lives have been saved through improved access to advanced healthcare interventions, highlighting the impact of modern medical technologies. This progress supports adoption of innovative treatments like biliary stents across developed healthcare systems.

Europe : Emerging Market with Growth Potential

Europe Biliary Stent Market was valued at USD 180.99 million in 2024, making it the second-largest regional market with a 28.13% share, driven by an aging population and increasing prevalence of biliary disorders. Regulatory support for innovative medical devices and a growing emphasis on patient-centric healthcare are key growth drivers. The region is witnessing a shift towards minimally invasive procedures, which is expected to enhance market demand. Additionally, favorable reimbursement policies are catalyzing the adoption of advanced biliary stents across various healthcare settings.

Leading countries in this market include Germany, France, and the UK, where healthcare infrastructure is robust. The competitive landscape features key players like B. Braun Melsungen AG and Terumo Corporation, who are focusing on product innovation and strategic partnerships. The presence of well-established healthcare systems and a strong emphasis on research and development further bolster the market's growth potential. The European market is set to become a significant player in the global biliary stents landscape.

  • The European Centre for Disease Prevention and Control (ECDC) highlights that chronic and digestive diseases continue to pose significant health challenges across Europe. Increasing adoption of advanced interventional procedures and medical devices supports improved patient outcomes, driving demand for biliary stents in modern healthcare systems.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific biliary stents market is anticipated to reach $120.0M by 2025, fueled by rising healthcare expenditures and a growing patient population suffering from biliary diseases. The region is experiencing rapid urbanization and an increase in lifestyle-related health issues, which are driving demand for advanced medical devices. Regulatory bodies are also becoming more supportive of innovative healthcare solutions, enhancing market growth prospects. The increasing focus on improving healthcare infrastructure is expected to further boost the market.

Countries like Japan, China, and India are leading the charge in this market, with significant investments in healthcare technology. The competitive landscape is marked by the presence of key players such as Olympus Corporation and Stryker Corporation, who are actively expanding their product portfolios. The region's diverse healthcare needs and the growing emphasis on quality care are likely to create lucrative opportunities for market players in the coming years.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) biliary stents market is projected to reach $20.66M by 2025, driven by increasing healthcare investments and a rising prevalence of biliary diseases. However, the market faces challenges such as limited access to advanced medical technologies and varying healthcare standards across countries. Regulatory frameworks are gradually evolving to support the introduction of innovative medical devices, which is expected to enhance market growth.

The demand for quality healthcare services is on the rise, prompting investments in healthcare infrastructure. Leading countries in the MEA region include South Africa and the UAE, where healthcare systems are improving. The competitive landscape is characterized by a mix of local and international players, with companies focusing on expanding their presence in the region. The market is expected to grow as healthcare access improves and awareness of biliary disorders increases, creating opportunities for key players to establish a foothold in this emerging market.

Biliary Stent Market Regional Image

Key Players and Competitive Insights

The Biliary Stents Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Boston Scientific (US), Medtronic (US), and Cook Medical (US) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Boston Scientific (US) has focused on developing advanced stent technologies that improve patient outcomes, while Medtronic (US) emphasizes a robust pipeline of minimally invasive solutions. Cook Medical (US) appears to be concentrating on expanding its global footprint, particularly in emerging markets, which may provide a competitive edge in a moderately fragmented market.
 
The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains. This approach not only enhances operational efficiency but also allows for quicker response times to market demands. The competitive structure of the Biliary Stents Market is moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they set industry standards and drive innovation through their extensive resources and expertise.
 

In November Boston Scientific (US) announced the launch of its latest biliary stent, which incorporates a novel drug-eluting technology designed to reduce the risk of restenosis. This strategic move is likely to enhance the company's market position by addressing a critical clinical need and potentially increasing its market share. The introduction of such innovative products may also compel competitors to accelerate their own development efforts, thereby intensifying competition.
 

In October Medtronic (US) entered into a strategic partnership with a leading healthcare technology firm to integrate AI-driven analytics into its biliary stent solutions. This collaboration aims to enhance patient monitoring and optimize treatment outcomes. The integration of AI technology could provide Medtronic (US) with a competitive advantage by offering more personalized treatment options, which may resonate well with healthcare providers seeking to improve patient care.
 

In September Cook Medical (US) expanded its manufacturing capabilities in Asia, aiming to meet the growing demand for biliary stents in the region. This expansion is strategically significant as it positions Cook Medical (US) to capitalize on emerging market opportunities, potentially increasing its market share in a region that is witnessing rapid healthcare advancements.
 

As of December current competitive trends in the Biliary Stents Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate to enhance their product offerings and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine market dynamics, compelling companies to invest in R&D and strategic partnerships to maintain a competitive edge.

Key Companies in the Biliary Stent Market include

Industry Developments

  • Q2 2024: REVA Medical Announces CE Mark Approval for Fantom Encore Bioresorbable Scaffold REVA Medical received CE Mark approval for its Fantom Encore bioresorbable scaffold, which is used in interventional procedures and distributed through a strategic partnership with B. Braun. This regulatory milestone enables commercial launch in select European markets.
  • Q2 2024: B. Braun and REVA Medical Announce Strategic Partnership for Fantom Encore Bioresorbable Scaffold B. Braun entered a strategic partnership with REVA Medical to distribute the Fantom Encore bioresorbable scaffold, strengthening its position in interventional cardiology and expanding its product portfolio in advanced scaffold technology.

Future Outlook

Biliary Stent Market Future Outlook

The Biliary Stents Market size is projected to reach USD 1,142.72 Million by 2035, growing at a CAGR of 5.36%.

New opportunities lie in:

  • Development of biodegradable biliary stents to enhance patient safety and reduce complications. Expansion into emerging markets with tailored product offerings to capture new customer segments. Investment in telemedicine solutions for remote monitoring of biliary stent patients.

By 2035, the Biliary Stents Market is expected to achieve robust growth, reflecting evolving healthcare needs.

Market Segmentation

Biliary Stents Market Type Outlook

  • Plastic Stents
  • Metal Stents
  • Covered Stents
  • Uncovered Stents

Biliary Stents Market Design Outlook

  • Straight Stents
  • Curved Stents
  • Expandable Stents

Biliary Stents Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Biliary Stents Market Material Outlook

  • Polymer
  • Metal
  • Silicone
  • Coated Materials

Biliary Stents Market Application Outlook

  • Biliary Obstruction
  • Biliary Stricture
  • Cholangiocarcinoma
  • Pancreatic Cancer

Report Scope

MARKET SIZE 2024 643.3(USD Million)
MARKET SIZE 2025 677.8(USD Million)
MARKET SIZE 2035 1142.72(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.36% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Boston Scientific (US), Medtronic (US), Cook Medical (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Hobbs Medical (US), ConMed Corporation (US), Olympus Corporation (JP), Stryker Corporation (US)
Segments Covered Application, Type, End User, Material, Design
Key Market Opportunities Advancements in biodegradable materials enhance efficacy and safety in the Biliary Stents Market.
Key Market Dynamics Rising demand for minimally invasive procedures drives innovation and competition in the biliary stents market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Biliary Stents Market by 2035?

The Biliary Stents Market is projected to reach a valuation of 1142.72 USD Million by 2035.

What was the market valuation of the Biliary Stents Market in 2024?

In 2024, the Biliary Stents Market was valued at 643.3 USD Million.

What is the expected CAGR for the Biliary Stents Market during the forecast period 2025 - 2035?

The expected CAGR for the Biliary Stents Market during the forecast period 2025 - 2035 is 5.36%.

Which application segment had the highest valuation in the Biliary Stents Market?

The Biliary Stricture application segment had a valuation range of 180.0 to 300.0 USD Million.

What are the key players in the Biliary Stents Market?

Key players in the Biliary Stents Market include Boston Scientific, Medtronic, and Cook Medical, among others.

How do metal stents compare to plastic stents in terms of market valuation?

Metal stents are valued between 200.0 and 350.0 USD Million, whereas plastic stents range from 150.0 to 250.0 USD Million.

What is the market valuation range for hospitals as end users in the Biliary Stents Market?

Hospitals, as end users, had a valuation range of 257.32 to 457.36 USD Million.

What is the projected growth trend for the Biliary Stents Market from 2024 to 2035?

The Biliary Stents Market is expected to grow from 643.3 USD Million in 2024 to 1142.72 USD Million by 2035.

Which end user segment is projected to have the highest valuation in the Biliary Stents Market?

Hospitals are projected to have the highest valuation among end user segments, ranging from 257.32 to 457.36 USD Million.

What is the valuation range for uncovered stents in the Biliary Stents Market?

Uncovered stents are valued between 113.3 and 242.72 USD Million.

Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative healthcare organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, World Health Organization (WHO) Global Health Observatory, Organisation for Economic Co-operation and Development (OECD) Health Statistics, American Society for Gastrointestinal Endoscopy (ASGE), Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), European Society of Gastrointestinal Endoscopy (ESGE), American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program, EU Eurostat Health Database, Medicare & Medicaid Services (CMS) Physician Fee Schedule and Procedure Data, National Health Service (NHS) England Hospital Episode Statistics, and national health ministry reports from key markets including Japan Ministry of Health, Labour and Welfare, China National Health Commission, and India Ministry of Health and Family Welfare. These sources were used to collect procedure statistics, regulatory approval data, clinical safety and efficacy studies, pancreaticobiliary disease incidence rates, demographic trends, and competitive landscape analysis for plastic biliary stents, metal biliary stents (uncovered SEMS, partially covered SEMS, fully covered SEMS), and drug-eluting biliary stents.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. CEOs, VPs of Product Development, regulatory affairs chiefs, R&D directors, and commercial directors from biliary stent manufacturers and OEMs are among the supply-side sources. Demand-side sources included procurement leads from hospitals and ambulatory surgical centers, medical directors of endoscopy units, interventional endoscopists, hepatobiliary surgeons, and interventional radiologists, as well as board-certified gastroenterologists. Market segmentation was validated, product pipeline timelines were confirmed, and clinical adoption patterns, stent patency rates, pricing strategies, reimbursement dynamics, and preferences between plastic and metal stent technologies were collated through primary research.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:

Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America

Product mapping across plastic biliary stents, uncovered self-expanding metal stents (SEMS), partially covered SEMS, fully covered SEMS, and drug-eluting biliary stents

Analysis of reported and modeled annual revenues specific to biliary stent portfolios

Coverage of manufacturers representing 72-78% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations for malignant obstruction applications, benign biliary stricture applications, and palliative drainage procedures

The percentages have been adjusted across all categories while maintaining logical distribution patterns appropriate for the biliary stents market, which has a slightly different stakeholder mix compared to dermal fillers given the hospital-centric procurement and interventional gastroenterology focus.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.